Psychotic Disorders of the Brain: Basic and Clinical Neuroscience Better Outcomes Cameron S. Carter MD Department of Psychiatry and Center for Neuroscience.

Slides:



Advertisements
Similar presentations
Combining neuropsychology and genetics in the study of mood disorders Daniel Smith MRCPsych Division of Psychiatry, University of Edinburgh Specialist.
Advertisements

Progress in Understanding the Neurobiology of Schizophrenia Daphne Holt, MD, PhD Director of Research, Schizophrenia Clinical and Research Program Department.
TMS-evoked EEG responses in symptomatic and recovered patients with mild traumatic brain injury Jussi Tallus 1, Pantelis Lioumis 2, Heikki Hämäläinen 3,
Psychosis in the Young Prof Chris Hollis Developmental Psychiatry Section Division of Psychiatry University of Nottingham.
Cellular, Behavioral, and Computational Investigations of Dopamine Modulation of Prefrontal Cortical Networks Jeremy Seamans.
Current knowledge on the pathophysiology of schizophrenia
Preventing the First Episode of Psychosis
Cognitive deficits in methamphetamine addiction Ronald E. See, Ph.D. Department of Neurosciences Medical University of South Carolina Charleston, SC 2011.
Understanding Cognitive Disability in Schizophrenia Cameron S. Carter MD University of California at Davis.
Methamphetamine and the Brain: A Problem of Inhibitory Control Edythe D. London, Ph.D. David Geffen School of Medicine, UCLA.
Surgeon General’s Report 1999 (Part 2) Mood Disorders and Schizophrenia.
UNIQUE CLINICAL SERVICES OF DEPARTMENT OF PSYCHIATRY John Lauriello, M.D. Professor and Vice Chair UNM Department of Psychiatry.
NEURAL CIRCUITRY UNDERLYING IMPAIRED INSIGHT IN SCHIZOPHRENIA: AN FMRI STUDY Mark Benton Department of Psychiatry and Behavioral Neuroscience.
Learning and Memory in Schizophrenia J. Daniel Ragland Department of Psychiatry & Behavioral Sciences UNIVERSITY OF CALIFORNIA AT DAVIS
Early-Onset Psychosis EARLY: Early Assessment and Resource Linkage for Youth May 15, 2008.
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Dementia with Lewy Bodies
A Visual Perceptual Task Provides Evidence for an Excitatory:Inhibitory Imbalance in Adults with Autism Jamie Horder, Mendez MA, Spain D, Faulkner J, De.
 Most drug use starts and peaks during adolescence  76.5% of all teens (
Dopamine pathways & antipsychotics Pharmacology Instructor Health Sciences Faculty University of Mendoza Argentina Psychiatry Resident Mental Health Teaching.
Psychlotron.org.uk Schizophrenia: brain chemicals How might neurotransmitters be implicated in mental illness?
B 尤思涵. Dopamine and Serotonin Dopamine 4-(2-aminoethyl)benzene-1,2-diol 5-Hydroxytryptamine or 3-(2-aminoethyl)-1H-indol-5-ol Serotonin.
Cahalans-Month-of-Madness/
Schizophrenia The Unwell Brain. Disturbance in the Neurochemistry  The first discovery in the mid 1950s was that chronic usage of large daily doses of.
Schizophrenia Monica Gindi Table of Contents IntroductionSymptomsOnsetCause Neurological effect DiagnosisManagement.
Team RITALIN: Research in Testing ADHD's Link to Impulsivity in Neuroscience 13 June 2013 Impact of prenatal nicotine exposure on impulsivity and neural.
Assertive Case Management & Feedback as a Clinical Intervention Linda May, PhD, MFT – Case Manager Rachel Loewy, PhD – Clinical Director.
Implications of Pediatric Brain-Related Disorders for the Clinical Psychologist APA Convention Washington, DC August 6, 2011 Department of Pediatrics Case.
Categories of Mental Disorders 1 Child and youth mental health problems can be classified into two broad categories: 1Internalizing problems  withdrawal.
Sackler Institute for Developmental Psychobiology Weill Medical College of Cornell University.
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
Schizophrenia: A neuro-developmental disorder of social and cognitive decline Demian Rose, MD, PhD.
George F. Koob, Ph.D. Director
PowerPoint  Lecture Notes Presentation
1 Chapter 16 Schizophrenia
Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder Jaeseung Jeong, Ph.D Department of Bio.
Changju Lee Visual System Neural Network Lab. Department of Bio and Brain Engineering.
Chapter 16 Schizophrenia
Neurocognitive Deficits in Schizophrenia Colin Hawco, PhD Oct York University.
ADOLESCENTS IN CRISIS: WHEN TO ADMIT FOR SELF-HARM OR AGGRESSIVE BEHAVIOR Kristin Calvert.
How well do we understand the neural origins of the fMRI BOLD signal? Owen J Arthurs and Simon Boniface Trends in Neuroscience, 2002 Gillian Elizabeth.
Copyright © 2007 by The McGraw-Hill Companies, Inc. All rights reserved. Schizophrenia.
Schizophrenia Overview. Schizophrenia is the most severe and debilitating mental illness in psychiatry and is a brain disorder.
Explanations of Schizophrenia Describe and evaluate both physiological and psychological explanations of Schizophrenia (25)
Announcement The following material related to the visual system will not be tested on the December exam: Lecture slides: Lecture 28, slides (on-
Chapter 8 Schizophrenia & Related Psychotic Disorders.
ABERRANT FUNCTIONAL CONNECTIVITY OF DL PFC AND CINGULATE NETWORKS IN PATIENTS WITH MDD DURING WORKING MEMORY PROCESSING By Sharleen Yuan Special Topics-Affective.
Selective Deficits in Prefrontal Cortex Function in Medication- Naïve Patients with Schizophrenia Deanna M. Barch, Cameron S. Carter, Todd S. Braver, Fred.
Understanding Cognitive Disability in Schizophrenia Cameron S. Carter MD University of California at Davis.
The brain at rest. Spontaneous rhythms in a dish Connected neural populations tend to synchronize and oscillate together.
Functional MRI David Card. fMRI So what exactly are we measuring in fMRI? Our goal is to “see” neural activity We are actually seeing changes in blood.
Introduction Results and Conclusions Comparisons of psychiatric hospitalization rates in the 12 months prior to and after baseline assessment revealed.
Alzheimer’s disease.
Medication for Psychosis: Myths and Truths Demian Rose, MD, PhD UCSF Assistant Professor PREP Medical Director PREP Prevention and Recovery of Early Psychosis.
The role of synchronous gamma-band activity in schizophrenia Jakramate 2009 / 01 / 14.
Cognitive Disorders Delirium, Dementia, Amnestic Disorders.
Neural Correlates of Symptom Reduction During TF-CBT JOSH CISLER, PHD BRAIN IMAGING RESEARCH CENTER PSYCHIATRIC RESEARCH INSTITUTE UNIVERSITY OF ARKANSAS.
Schizophrenia A. Schizophrenia is a group of severe disorders characterized by the breakdown of personality functioning, withdrawal from reality, distorted.
PSYCHOTIC DISORDER Mental Health First Aid By Mental Health Commission of Canada, 2010.
Treatment of auditory verbal hallucinations in schizophrenia using tDCS Charlotte Chaze 1, Vince P. Clark 1,2, Jessica Turner 1,3, Rose Bigelow 2, Jason.
Modelling Madness Susan Totterdell.
Dopamine system: neuroanatomy
The Dopamine Hypothesis Part 2
Is it a potential indicator to initiate HAART?
DOPAMINE HYPOTHESIS.
Dopamine pathways & antipsychotics
Schizophrenia: brain chemicals
Volume 73, Issue 4, Pages (February 2012)
Progress Seminar 권순빈.
Wallis, JD Helen Wills Neuroscience Institute UC, Berkeley
Presentation transcript:

Psychotic Disorders of the Brain: Basic and Clinical Neuroscience Better Outcomes Cameron S. Carter MD Department of Psychiatry and Center for Neuroscience

Overview What we know about brain pathology in schizophrenia and bipolar disorder How we are using this knowledge to improve outcomes

3 types of symptoms Positive Negative Cognitive/disorganization

Is schizophrenia a brain disorder?

JOHNSTONE AND CROW LANCET 1976

Effects of hemodynamic activation on BOLD signal in the brain: a) paramagnetic properties of Hb and b) overly zealous regulation of perfusion of the brain

Higher Cognitive Functions In Schizophrenia Attention Memory Language Disturbances Emotional processing Manifestation of Impaired Cognitive Control

Cognitive Control..when habitual responding won’t do and you have to use a representation of a task or goal to guide behavior…

GREEN

Gross Functional Impairment in the Brain Macrocircuit Abnormalities Yoon et al, American J. Psychiatry 2008

Neuronal Oscillations? * Encoding and processing occurs when a population of neurons fires at the same time AND with the same frequency. Asynchronous firing Synchronous firing Sometimes populations of neurons will fire at different times from each other (asynchronously), and sometimes they fire together (synchronously).

Frontal Cortical Induced Gamma Band Activity

Disrupted cortical function in schizophrenia Selective reduction in gray matter thickness Subtle alterations in cellular structure and function, unbalancing excitation and inhibition Disrupted local circuit function Loss of prefrontal control of networks Negative symptoms and cognitive impairment What about positive symptoms?

McGlashan 1984-the Chestnut lodge study

Alterations in dopamine neurotransmission The classical dopamine hypothesis (too much dopamine in schizophrenia) rested on the observation that DA releasing drugs can cause psychosis, and the discovery that antipsychotics were dopamine antagonists.

Alterations in dopamine neurotransmission C11 Racolpride displacement reflects DA release

Increased subcortical DA related to psychosis

Alterations in dopamine neurotransmission Decreased prefrontal activity (DA based or otherwise) may lead to subcortical DA dysregulation and psychosis Decreased PFC function VTA Increased DA +

Improving Outcomes New therapies for negative symptoms and cognitive impairments –Medication treatments –Brain training –Brain Stimulation Early Intervention

Medication Treatment for Cognitive and Negative Symptoms Not dopamine blockers, added on to antipsychotic treatment Most target cortical function, especially the prefrontal cortex Increase neuromodulators, dopamine, norepinephrine, cholinergic/nicotinic, gaba-ergic to improve local circuit function No unequivocal successes yet but progress

Cognitive Training Many approaches being developed Not just for schizophrenia, also ADHD, MCI

Vinogradov/Posit Science Study Protocol AUDITORY MODULE 50 hours VISUAL MODULE 30 hours COGN. CONTROL MODULE 20 hours Assessment Assessments:Clinical and Neuropsych Bloods (BDNF, serum antichol, plasms neuroleptic levels) MEG, fMRI

Baseline Cognitive Performance Auditory Training Subject Group (AT) N = 40 Computer Games Control Group (CG) N = 30

Change in Cognitive Performance post-training minus baseline age-adjusted z-scores 50 hours of computerized neuroplasticity-based auditory training (AT) vs. 50 hours of a computer games (CG) control condition. Results of Repeated Measures ANOVA, controlling for age and baseline cognitive performance, showed significant differences between AT and CG subject groups on measures of Global Cognition, Verbal Learning and Memory, and Verbal Working Memory at trend level.

PRELIMINARY 6-MONTH DATA: DURABILITY (AT = 22, CG = 10) Fisher, Holland, Subramaniam, Vinogradov, Schiz Bull, 2009

Brain Stimulation Transcranial Magnetic Stimulation Direct Current Stimulation

Early Intervention for Psychosis Duration of untreated psychosis a strong predictor of treatment response and long term outcome Typically about 18 months in the US Early identification and intervention to brain this down Established psychosis The “psychosis risk syndrome”

PACE, PRIME, OPUS and PIER 12 month outcome

EDAPT Model Family based approach Rapid, crisis-oriented initiation of treatment Expert evaluation of clinical and risk status!!! Psychoeducational multifamily groups Case management and Medical Management using key Assertive Community Treatment methods –Integrated, multidisciplinary team; rapid response; continuous case review –Targeted pharmacological intervention as needed!!! Supported employment and education Collaboration with schools, colleges and employers Substance abuse treatment, as indicated Detailed outcomes measurement The EDAPT Program/SacEDAPT

U.C. Davis Innovation Overcoming Schizophrenia and Bipolar Disorder Overcoming Schizophrenia and Bipolar Disorder 1 person at a time Basic research into brain development and function CENTER FOR NEUROSCIENCE Early Intervention EDAPT/SacEDAPT Novel Treatments for Cognitive Deficits and Negative Symptoms TCAN Group

Division of Clinical Neuroscience UC Davis Friends of Psychiatry

REGISTER ONLINE AT